Allan R. Ferguson

Xthetix, Inc. develops medical devices. It develops, manufactures and markets novel therapeutic ultrasound products for aesthetics market. The company's products are used in professional dermatology and plastic surgery markets. Xthetix was co-founded by Michael H. Slayton and Brian D. O'Connor in 2006 and is headquartered in Mesa, AZ.

AutoImmune, Inc. develop products to treat autoimmune and other cell-mediated inflammatory conditions. Its products are based on a biological mechanism known as oral tolerance, which provides tissue specific immunosuppression without toxicity or significant side effects. The company was founded in September 1988 and is headquartered in Pasadena, CA.

3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III).

Integrity Venture Services LLC(Vista Ventures) is an Independent Venture Capital firm founded in 2000 by Catharine Merigold and Dave E. Dwyer. The Firm is headquartered in Boulder.

ZONARE Medical Systems, Inc. designs, develops and manufactures ultrasound solutions. The firm offers ultrasound systems; curved array, curved-phased array, linear array, phased array, endocavity, and continuous wave transducers; accessories, such as transducer biopsy guides and user interface sterile covers; and upgrades, including imaging, workflow, and clinical enhancements. The company was founded by Mir A. Imran and Glen W. McLaughlin in 1999 and is headquartered in Mountain View, CA.

Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC.

Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.